KR101847375B1 - Dandelion mixed extract composition for improving brain comfort when tasting and uses thereof - Google Patents
Dandelion mixed extract composition for improving brain comfort when tasting and uses thereof Download PDFInfo
- Publication number
- KR101847375B1 KR101847375B1 KR1020170108824A KR20170108824A KR101847375B1 KR 101847375 B1 KR101847375 B1 KR 101847375B1 KR 1020170108824 A KR1020170108824 A KR 1020170108824A KR 20170108824 A KR20170108824 A KR 20170108824A KR 101847375 B1 KR101847375 B1 KR 101847375B1
- Authority
- KR
- South Korea
- Prior art keywords
- dandelion
- comfort
- mixed extract
- lobe
- brain
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 39
- 239000000203 mixture Substances 0.000 title claims abstract description 32
- 210000004556 brain Anatomy 0.000 title claims abstract description 30
- 240000001949 Taraxacum officinale Species 0.000 title claims description 59
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 title claims description 58
- 238000001228 spectrum Methods 0.000 claims abstract description 39
- 210000001152 parietal lobe Anatomy 0.000 claims abstract description 12
- 230000003595 spectral effect Effects 0.000 claims abstract description 11
- 235000013376 functional food Nutrition 0.000 claims abstract description 8
- 230000036541 health Effects 0.000 claims abstract description 8
- 210000002442 prefrontal cortex Anatomy 0.000 claims abstract description 7
- 102100021709 Rho guanine nucleotide exchange factor 4 Human genes 0.000 claims abstract 2
- 101710128386 Rho guanine nucleotide exchange factor 4 Proteins 0.000 claims abstract 2
- 235000020691 dandelion extract Nutrition 0.000 claims description 22
- 229940067866 dandelion extract Drugs 0.000 claims description 20
- 239000001845 taraxacum officinale leaf extract Substances 0.000 claims description 20
- 239000012141 concentrate Substances 0.000 claims description 17
- 239000000843 powder Substances 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 230000002708 enhancing effect Effects 0.000 claims description 14
- 240000006439 Aspergillus oryzae Species 0.000 claims description 7
- 235000002247 Aspergillus oryzae Nutrition 0.000 claims description 7
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 7
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 7
- 210000000869 occipital lobe Anatomy 0.000 claims description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 150000003839 salts Chemical class 0.000 claims description 4
- 210000003478 temporal lobe Anatomy 0.000 claims description 4
- 239000000796 flavoring agent Substances 0.000 claims description 3
- 235000019634 flavors Nutrition 0.000 claims description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 3
- 239000011707 mineral Substances 0.000 claims description 3
- 235000010755 mineral Nutrition 0.000 claims description 3
- 229930003231 vitamin Natural products 0.000 claims description 3
- 239000011782 vitamin Substances 0.000 claims description 3
- 235000013343 vitamin Nutrition 0.000 claims description 3
- 229940088594 vitamin Drugs 0.000 claims description 3
- 241001105098 Angelica keiskei Species 0.000 claims description 2
- 229920002230 Pectic acid Polymers 0.000 claims description 2
- 241000245665 Taraxacum Species 0.000 claims description 2
- 239000000783 alginic acid Substances 0.000 claims description 2
- 235000010443 alginic acid Nutrition 0.000 claims description 2
- 229920000615 alginic acid Polymers 0.000 claims description 2
- 229960001126 alginic acid Drugs 0.000 claims description 2
- 150000004781 alginic acids Chemical class 0.000 claims description 2
- 235000014171 carbonated beverage Nutrition 0.000 claims description 2
- 239000003086 colorant Substances 0.000 claims description 2
- 210000005153 frontal cortex Anatomy 0.000 claims description 2
- 235000011187 glycerol Nutrition 0.000 claims description 2
- 239000003002 pH adjusting agent Substances 0.000 claims description 2
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 claims description 2
- 239000010318 polygalacturonic acid Substances 0.000 claims description 2
- 239000003755 preservative agent Substances 0.000 claims description 2
- 230000001681 protective effect Effects 0.000 claims description 2
- 239000003381 stabilizer Substances 0.000 claims description 2
- 244000126002 Ziziphus vulgaris Species 0.000 claims 1
- 235000013527 bean curd Nutrition 0.000 claims 1
- 239000000084 colloidal system Substances 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 150000007524 organic acids Chemical class 0.000 claims 1
- 235000005985 organic acids Nutrition 0.000 claims 1
- 239000002562 thickening agent Substances 0.000 claims 1
- 210000001652 frontal lobe Anatomy 0.000 abstract description 11
- 238000004519 manufacturing process Methods 0.000 abstract description 8
- 241000691199 Taraxacum platycarpum Species 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 7
- 238000000034 method Methods 0.000 abstract description 6
- 210000000867 larynx Anatomy 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 12
- 241001247821 Ziziphus Species 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 4
- 241000208838 Asteraceae Species 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 230000007177 brain activity Effects 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 241000208340 Araliaceae Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 241000222336 Ganoderma Species 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 230000002360 prefrontal effect Effects 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- XWMMEBCFHUKHEX-MRTCRTFGSA-N (+)-Taraxasterol Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CC[C@]1(C)[C@@H]2CC[C@H]2[C@@H]3[C@H](C)C(=C)CC[C@]3(C)CC[C@]21C XWMMEBCFHUKHEX-MRTCRTFGSA-N 0.000 description 1
- QMKPCZNFLUQTJZ-UHFFFAOYSA-N (4aR)-10c-Hydroxy-1t.2c.4ar.6at.6bc.9.9.12ac-octamethyl-(8atH.12btH.14acH.14btH)-docosahydro-picen Natural products CC1CCC2(C)CCC3(C)C(CCC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C QMKPCZNFLUQTJZ-UHFFFAOYSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 241000801074 Agoseris Species 0.000 description 1
- 240000001810 Angelica gigas Species 0.000 description 1
- 235000018865 Angelica gigas Nutrition 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- 241000412169 Peria Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241001272081 Taraxacum coreanum Species 0.000 description 1
- 241000292546 Taraxacum mongolicum Species 0.000 description 1
- 235000006754 Taraxacum officinale Nutrition 0.000 description 1
- -1 Taraxathin Chemical class 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 235000020831 absolute fast Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000037007 arousal Effects 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N cinnamic acid group Chemical class C(C=CC1=CC=CC=C1)(=O)O WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- 230000003920 cognitive function Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 210000004443 dendritic cell Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000000624 ear auricle Anatomy 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- XTLWNMXYCHABQH-UHFFFAOYSA-N germanicol Natural products CC1(C)CCC2(C)CCC3(C)C(CCC4(C)C5(C)CCC(O)C(C)(C)C5CCC34C)C2=C1 XTLWNMXYCHABQH-UHFFFAOYSA-N 0.000 description 1
- 229940107131 ginseng root Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 235000021109 kimchi Nutrition 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 208000015238 neurotic disease Diseases 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000021110 pickles Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- NGFFRJBGMSPDMS-UHFFFAOYSA-N psi-Taraxasterol Natural products CC12CCC(O)C(C)(C)C1CCC1(C)C2CCC2C3C(C)C(C)=CCC3(C)CCC21C NGFFRJBGMSPDMS-UHFFFAOYSA-N 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 229940035637 spectrum-4 Drugs 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- HUTYZQWCTWWXND-NCTFTGAASA-N taraxasterol Natural products C[C@H]1[C@H]2C3=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)C[C@H](O)[C@@]2(C)CCC1=C HUTYZQWCTWWXND-NCTFTGAASA-N 0.000 description 1
- GGGUGZHBAOMSFJ-GADYQYKKSA-N taraxerol Chemical compound CC([C@@H]1CC2)(C)[C@@H](O)CC[C@]1(C)[C@@H]1[C@]2(C)C2=CC[C@@]3(C)CCC(C)(C)C[C@H]3[C@]2(C)CC1 GGGUGZHBAOMSFJ-GADYQYKKSA-N 0.000 description 1
- HYTFUKZLSYXRDX-UHFFFAOYSA-N taraxerol Natural products CC1CCCC2C3(C)CCC4(C)C5CC(C)(C)CCC5(C)C=CC4(C)C3C(O)CC12C HYTFUKZLSYXRDX-UHFFFAOYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/065—Microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
본 발명은 시음시 좌측 전전두엽, 우측 전두엽, 좌측 후두엽, 우측 후두엽, 중앙 후두엽, 우측 두정엽, 중앙 두정엽 및 좌측 두정엽에서 RFA(Relative fast alpha power spectrum)의 증가와 중앙 전전두엽에서 ASEF(Spectral edge frequency 50% of alpha spectrum band)의 증가를 유도하여 두뇌의 쾌적성을 증진시키는 민들레 혼합 추출액 조성물, 상기 민들레 혼합 추출액 조성물을 포함하는 두뇌 쾌적성 증진용 건강기능식품, 두뇌 쾌적 증진 효과를 지니는 민들레 혼합 추출액의 제조방법 및 상기 방법으로 제조된 민들레 혼합 추출액에 관한 것이다.
The present invention is based on an increase in RFA (relative fast alpha power spectrum) and an increase in ASEF (spectral edge frequency 50%) in the middle prefrontal cortex in the left prefrontal cortex, right frontal cortex, left frontal lobe, right frontal lobe, medial parietal lobe, of alpha spectrum band in order to enhance the comfort of the brain, a health functional food for enhancing brain comfort, which comprises the above-mentioned dandelion mixed extract composition, and a dandelion mixed extract having brain-improving effect And a dandelion mixed extract prepared by the above method.
민들레는 국화과(Compositae)에 속하는 다년생 식물로 우리나라 전역에는 식용가능한 좀민들레(Taraxacum hallanisanese), 산민들레(T. ohwianum), 흰민들레(T. coreanum), 서양민들레(T. officinale), 토종민들레(T. mongolicum)가 서식하고 있다(이, 1996).Dandelion is a perennial plant belonging to the family Asteraceae (Compositae). It is a perennial plant belonging to the family Asteraceae ( Taraxacum hallanisanese ), mountain dandelion ( T. ohwianum ), white dandelion ( T. coreanum ), T. officinale , T. mongolicum ) is inhabited (Lee, 1996).
우리나라에서 민들레는 다양하게 활용되고 있는데 어린잎은 나물로, 뿌리는 약용으로 사용되고 있다. 한방에서는 민들레 뿌리를 포공영, 포공초, 금잠로, 지정이라 하여 종기, 결핵, 해열, 최유, 황달, 간질 치료에 사용하고 있으며, 유럽에서는 변비, 류마티스, 노이로제, 야맹증 예방과 치료에 그리고 북미에서는 커피 대용품으로 사용하고 있다.Dandelion is widely used in Korea. Young leaves are used as herbs, and roots are used as medicines. It is used in the treatment of constipation, rheumatism, neurosis, and blindness in Europe, and in Europe, in the treatment of constipation, tuberculosis, epilepsy, It is used as a substitute.
민들레 잎은 비타민과 무기질이 풍부하고, 지방함량과 칼로리가 낮아 식품영양학적으로 뛰어난 웰빙 식품으로 적당하며, 고미성분인 타락신(taraxcin), 이눌린(inulin)이 많고, 카로티노이드(carotenoid) 성분인 타락사신(taraxathin), 트리터펜(triterpene)인 타락세롤(taraxerol), 타락사스테롤(taraxasterol), β-시토스테롤(β-sitosterol), 그리고 카페인산(caffeic acid) 등과 비타민 A, 비타민 C, 토코페롤(tocopherol), 칼슘(Ca), 철(Fe), 칼륨(K) 등이 풍부하다.The dandelion leaves are rich in vitamins and minerals, low in fat content and calories, suitable for nutritionally good well-being foods, and contain a lot of taraxin, inulin, and carotenoid, Taraxathin, triterpene taraxerol, taraxasterol, β-sitosterol, and caffeic acid, as well as vitamin A, vitamin C, tocopherol, ), Calcium (Ca), iron (Fe), and potassium (K).
민들레에 함유되어 있는 고미성분인 타락사신은 소화촉진 및 간기능향상 효과가 있으며(Kim. 1997. Studies on the steorl and steryl glycoside of dandelion. J. Sangji Univ. 18:409-414), 루테올린은 간기능 증진과 개선효과가 탁월하며(Williams et al. 1996. Flavonoid, cinnamic acids and coumarins from the different tissues and medicinal preparation of Taraxacum officinale. Phytochem. 42:121-127), 민들레 에탄올 추출물은 항알러지, 항염증, 항종양, 항암활성이 보고되었다(Ho et al. 1998. Desacetylmartricarin and anti-allegic component from Taraxacum platycarpum. Planta Med. 64:577-578).In this study, we investigated the effects of ginseng root extracts on the growth of dendritic cells, liver function promoting and improving effect is excellent, and (Williams et al 1996. Flavonoid, cinnamic acids and coumarins from the different tissues and medicinal preparation of Taraxacum officinale Phytochem 42:... 121-127), dandelion ethanol extract of anti-allergy, anti- Inflammatory, antitumor, and anticancer activities have been reported (Ho et al., 1998. Desacetylmartricarin and anti-allegic components from Taraxacum platycarpum. Planta Med. 64: 577-578).
최근에는 민들레의 효능을 이용하여 민들레 김치, 민들레 비누, 민들레차, 민들레 향수, 민들레 진액, 민들레 엑기스, 민들레 한과, 민들레 초콜릿, 민들레 찐빵과 같은 다양한 가공상품이 개발되어 판매되고 있다(양구민들레RIS 사업단. 2017. 양구민들레컨버전스산업체계구축사업 최종 보고서).
Recently, a variety of processing products such as dandelion kimchi, dandelion soap, dandelion tea, dandelion fragrance, dandelion extract, dandelion extract, dandelion flower, dandelion chocolate, and dandelion steamed bread have been developed and marketed using the efficacy of dandelion 2017. Yanggu Dandelion Convergence Industry System Project Final Report).
본 발명은 상기와 같은 요구에 의해 도출된 것으로서, 본 발명자들은 민들레 혼합 추출액 조성물을 이용하여 뇌파 변화를 분석한 결과, 본 발명의 민들레 혼합 추출액 조성물은 좌측 전전두엽, 우측 전두엽, 좌측 후두엽, 우측 후두엽, 중앙 후두엽, 우측 두정엽, 중앙 두정엽 및 좌측 두정엽에서 RFA(Relative fast alpha power spectrum)의 증가를, 중앙 전전두엽에서 ASEF(Spectral edge frequency 50% of alpha spectrum band)의 증가를 유도하는 것을 확인함으로써, 본 발명을 완성하였다.
As a result of analyzing EEG changes using the dandelion mixed extract composition, the present inventors have found that the dandelion mixed extract composition of the present invention can be applied to the left frontal lobe, the right frontal lobe, the left larynx, By confirming the increase of RFA (relative fast alpha power spectrum) in the central occipital lobe, right parietal lobe, central parietal lobe and left parietal lobe and increase of ASEF (spectral edge frequency 50% of alpha spectrum band) .
상기 과제를 해결하기 위해, 본 발명은 발효 민들레 추출액, 대추 농축액 및 당귀 농축액을 혼합한 혼합물을 유효성분으로 함유하는 두뇌 쾌적성 증진용 민들레 혼합 추출액 조성물을 제공한다.In order to solve the above problems, the present invention provides a mixed extract composition of dandelion for improving brain comfort comprising a mixture of fermented dandelion extract, jujube concentrate and Angelica giganteum concentrate as an active ingredient.
또한, 본 발명은 상기 민들레 혼합 추출액 조성물을 포함하는 두뇌 쾌적성 증진용 건강기능식품을 제공한다.In addition, the present invention provides a health functional food for enhancing brain comfort comprising the above-described mixed extract composition of dandelion.
또한, 본 발명은 (a) 민들레 분말, 프락토올리고당 분말 및 아스퍼질러스 오리재(Aspergillus oryzae) 균주를 혼합한 후 물을 첨가하여 발효한 발효물에 물을 첨가한 후 추출하여 발효 민들레 추출액을 제조하는 단계; 및 (b) 상기 (a)단계의 제조한 발효 민들레 추출액과 대추 농축액 및 당귀 농축액을 혼합하는 단계를 포함하는 두뇌 쾌적 증진 효과를 지니는 민들레 혼합 추출액의 제조방법을 제공한다.The present invention also relates to a composition comprising (a) a dandelion powder, a fructooligosaccharide powder and an Aspergillus oryzae ), adding water thereto, adding water to the fermented fermented product, and extracting the fermented product to prepare a fermented dandelion extract; And (b) mixing the fermented dandelion extract prepared in step (a) with a jujube concentrate and a Ganoderma concentrate to prepare a mixed extract of dandelion having a brain-cooling enhancing effect.
또한, 본 발명은 상기 방법으로 제조된 두뇌 쾌적 증진 효과를 지니는 민들레 혼합 추출액을 제공한다.
The present invention also provides a mixed extract of dandelion having the brain-comfort enhancing effect prepared by the above-described method.
본 발명의 민들레 혼합 추출액 조성물은 민들레 혼합 추출액 섭취를 통해, 좌측 전전두엽, 우측 전두엽, 좌측 후두엽, 우측 후두엽, 중앙 후두엽, 우측 두정엽, 중앙 두정엽 및 좌측 두정엽에서 RFA(Relative fast alpha power spectrum)의 증가를 유도하고, 중앙 전전두엽에서 ASEF(Spectral edge frequency 50% of alpha spectrum band)의 증가를 유도하여 두뇌 쾌적 증진 효과를 얻을 수 있다. 또한, 본 발명의 민들레 혼합 추출액 조성물을 식품에 첨가하여 두뇌 쾌적 증진 효과를 유도하는 건강기능식품의 개발에 사용될 수 있다.
The mixed extract composition of dandelion of the present invention showed an increase in relative fast alpha power spectrum (RFA) in the left prefrontal cortex, the right frontal lobe, the left occipital lobe, the right occipital lobe, the central occipital lobe, the central parietal lobe and the left parietal lobe (ASEF) in the central pharyngeal lobe, and the brain enhancement effect can be obtained by inducing an increase in the ASEF (spectral edge frequency 50% of the alpha spectrum band). In addition, the present invention can be used for the development of a health functional food which induces a brain-comfort enhancing effect by adding a dandelion mixed extract composition to a food.
도 1은 뇌파 측정을 위해 인간의 두뇌에 전극을 붙이는 부위를 제시한 10-20 국제표준 전극부착법을 보여주는 사진이다.
도 2는 피험자의 두뇌에 EGG용 모자를 씌우고 뇌파를 측정하는 모습을 보여주는 사진이다.
도 3은 물 시음(좌측)과 민들레 혼합 추출액 시음(우측) 후 RFA(Relative fast alpha power spectrum) 변화를 보여주는 뇌지도 맵핑 결과이다.
도 4는 물 시음(좌측)과 민들레 혼합 추출액 시음(우측) 후 ASEF(Spectral edge frequency 50% of alpha spectrum band) 변화를 보여주는 뇌지도 맵핑 결과이다.FIG. 1 is a photograph showing a 10-20 international standard electrode attaching method showing a region where an electrode is attached to a human brain for EEG measurement.
FIG. 2 is a photograph showing an EGG cap placed on a subject's brain and measuring brain waves.
FIG. 3 shows a brain map mapping result showing changes in RFA (relative fast alpha power spectrum) after a water tasting (left) and a tasting of dandelion mixed extract (right).
FIG. 4 is a map of the brain map showing changes in the ASEF (spectral edge frequency 50% of the alpha spectrum band) after the water tasting (left) and tasting of the dandelion mixed extract (right).
본 발명의 목적을 달성하기 위하여, 본 발명은 발효 민들레 추출액, 대추 농축액 및 당귀 농축액을 혼합한 혼합물을 유효성분으로 함유하는 두뇌 쾌적성 증진용 민들레 혼합 추출액 조성물을 제공한다.In order to achieve the object of the present invention, the present invention provides a mixed extract composition of dandelion for improving brain comfort comprising a mixture of a fermented dandelion extract, a jujube concentrate and a ginseng concentrate as an active ingredient.
본 발명의 두뇌 쾌적성 증진용 민들레 혼합 추출액 조성물에서, 상기 혼합물은 구체적으로는 민들레 분말, 프락토올리고당 분말 및 아스퍼질러스 오리재(Aspergillus oryzae) 균주를 94~96:4~6:0.08~0.12 중량비율로 혼합한 후 물을 첨가하여 30~45℃에서 48~72시간 동안 발효한 발효물에 물을 발효물 대비 5~20배(v/w) 첨가하여 95~100℃에서 8~16시간 동안 추출한 발효 민들레 추출액 94~96 중량%, 대추 농축액 2~4 중량% 및 당귀 농축액 1.5~2.5 중량%를 혼합한 혼합물일 수 있으며, 더욱 구체적으로는 민들레 분말, 프락토올리고당 분말 및 아스퍼질러스 오리재(Aspergillus oryzae) 균주를 95:4.9:0.1 중량비율로 혼합한 후 물을 첨가하여 37℃에서 48~72시간 동안 발효한 발효물에 물을 발효물 대비 10배(v/w) 첨가하여 97℃에서 12시간 동안 추출한 발효 민들레 추출액 95 중량%, 대추 농축액 3 중량% 및 당귀 농축액 2 중량%를 혼합한 혼합물일 수 있다.In the dandelion mixed extract composition for enhancing brain comfort of the present invention, the mixture is preferably a dandelion powder, a fructooligosaccharide powder and an Aspergillus oryzae were mixed at 94 ~ 96: 4 ~ 6: 0.08 ~ 0.12 weight ratio, water was added and the fermented product was fermented at 30 ~ 45 ℃ for 48 ~ 72 hours. , a mixture of 94 to 96% by weight of fermented dandelion extract extracted at 95 to 100 ° C for 8 to 16 hours, 2 to 4% by weight of a jujube concentrate and 1.5 to 2.5% by weight of a concentrate of Angelica keiskei koidz. Specifically, dandelion powder, fructo-oligosaccharide powder, and Aspergillus oryzae were mixed at a weight ratio of 95: 4.9: 0.1, water was added, and water was added 10 times (v / w) to the fermented product fermented at 37 ° C for 48 to 72 hours, 95% by weight of fermented dandelion extract, 3% by weight of jujube concentrate, and 2% by weight of Angelica gigas Lacticum concentrate.
본 발명의 민들레 혼합 추출액 조성물은 좌측 전전두엽, 우측 전두엽, 좌측 후두엽, 우측 후두엽, 중앙 후두엽, 우측 두정엽, 중앙 두정엽 및 좌측 두정엽에서 RFA(Relative fast alpha power spectrum)의 증가를, 중앙 전전두엽에서 ASEF(Spectral edge frequency 50% of alpha spectrum band)의 증가를 유도하여 두뇌 쾌적 증진 효과를 나타내는 것을 특징으로 한다.The mixed extract composition of dandelion according to the present invention has an increase in relative fast alpha power spectrum (RFA) in the left prefrontal region, a right frontal lobe, a left frontal lobe, a right frontal lobe, a middle laryngeal lobe, edge frequency 50% of the alpha spectrum band), thereby exhibiting a brain-comfort enhancing effect.
RFA의 증가는 뇌파 전체에서 빠른 알파파(fast alpha wave)의 비율이 증가하는 것을 의미한다. 빠른 알파파가 증가하면 뇌를 각성시켜 집중력을 향상시키면서도 안정감과 편안함을 느낄 수 있는 상태가 된다. ASEF는 Alpha파의 SEF50를 의미하며, ASEF의 증가는 Fast Alpha파의 비율이 증가했다는 것을 의미하며, 쾌적성 수준을 평가할 때 사용된다.The increase in RFA means that the ratio of fast alpha waves increases in the entire EEG. As the rapid increase in ALPA increases the concentration of the brain by awakening the brain, you can feel the sense of stability and comfort. ASEF means Alpha wave SEF50, and the increase in ASEF means that the rate of Fast Alpha wave increases, and it is used to evaluate comfort level.
또한, 본 발명은 상기 민들레 혼합 추출액 조성물을 포함하는 두뇌 쾌적성 증진용 건강기능식품을 제공한다.In addition, the present invention provides a health functional food for enhancing brain comfort comprising the above-described mixed extract composition of dandelion.
상기 건강기능식품은 여러 가지 영양제, 비타민, 광물(전해질), 합성 및 천연 풍미제, 착색제 및 증진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산음료에 사용되는 탄산화제 등을 함유할 수 있다. 그 밖에 천연 과일 주스 및 야채 음료의 제조를 위한 과육을 함유할 수 있다. 이러한 성분은 독립적으로 또는 조합하여 사용할 수 있다. The health functional food may contain various nutrients, vitamins, minerals (electrolytes), synthetic and natural flavors, colorants and enhancers (cheese, chocolate etc.), pectic acid and its salts, alginic acid and its salts, pH adjusting agents, stabilizers, preservatives, glycerin, alcohols, carbonating agents used in carbonated drinks, and the like. It may also contain flesh for the production of natural fruit juices and vegetable drinks. These components may be used independently or in combination.
본 발명의 건강기능식품은 여러가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다. 상기 천연 탄수화물은 포도당, 과당과 같은 모노사카라이드, 말토스, 슈크로스와 같은 디사카라이드, 및 덱스트린, 사이클로덱스트린과 같은 폴리사카라이드, 자일리톨, 소르비톨, 에리트리톨 등의 당알콜이다. 감미제로서는 타우마틴, 스테비아 추출물과 같은 천연 감미제나, 사카린, 아스파르탐과 같은 합성 감미제 등을 사용할 수 있다.The health functional food of the present invention may contain various flavors or natural carbohydrates as an additional ingredient. The natural carbohydrates are sugar saccharides such as monosaccharides such as glucose and fructose, disaccharides such as maltose and sucrose, polysaccharides such as dextrin and cyclodextrin, xylitol, sorbitol and erythritol. Examples of sweeteners include natural sweeteners such as tau martin and stevia extract, synthetic sweeteners such as saccharin and aspartame, and the like.
본 발명은 또한,The present invention also relates to
(a) 민들레 분말, 프락토올리고당 분말 및 아스퍼질러스 오리재(Aspergillus oryzae) 균주를 94~96:4~6:0.08~0.12 중량비율로 혼합한 후 물을 첨가하여 30~45℃에서 48~72시간 동안 발효한 발효물에 물을 발효물 대비 5~20배(v/w) 첨가하여 95~100℃에서 8~16시간 동안 추출하여 발효 민들레 추출액을 제조하는 단계; 및(a) Dandelion powder, fructooligosaccharide powder and Aspergillus oryzae strain are mixed in a weight ratio of 94 to 96: 4 to 6: 0.08 to 0.12, water is added, Adding water to the fermented fermented product for 72 hours at a rate of 5 to 20 times (v / w) relative to the fermented product and extracting the fermented dandelion extract at 95 to 100 ° C for 8 to 16 hours; And
(b) 민들레 혼합 추출액 총 중량 기준으로, 상기 (a)단계의 제조한 발효 민들레 추출액 94~96 중량%와 대추 농축액 2~4 중량% 및 당귀 농축액 1.5~2.5 중량%를 혼합하는 단계를 포함하는 두뇌 쾌적 증진 효과를 지니는 민들레 혼합 추출액의 제조방법을 제공한다.(b) mixing 94 to 96% by weight of the fermented dandelion extract prepared in step (a) with 2 to 4% by weight of a jujube concentrate and 1.5 to 2.5% by weight of a ganoderma concentrate, based on the total weight of the dandelion mixed extract liquid A method for producing a dandelion mixed extract having a brain-comfort enhancing effect is provided.
본 발명의 두뇌 쾌적 증진 효과를 지니는 민들레 혼합 추출액의 제조방법은, 보다 구체적으로는The method for producing a dandelion mixed extract having the brain-comfort enhancing effect of the present invention, more specifically,
(a) 민들레 분말, 프락토올리고당 분말 및 아스퍼질러스 오리재(Aspergillus oryzae) 균주를 95:4.9:0.1 중량비율로 혼합한 후 물을 첨가하여 37℃에서 48~72시간 동안 발효한 발효물에 물을 발효물 대비 10배(v/w) 첨가하여 97℃에서 12시간 동안 추출하여 발효 민들레 추출액을 제조하는 단계; 및(a) Dandelion powder, fructooligosaccharide powder and Aspergillus oryzae strain were mixed in a weight ratio of 95: 4.9: 0.1, water was added, and the resulting fermented product was fermented at 37 DEG C for 48 to 72
(b) 민들레 혼합 추출액 총 중량 기준으로, 상기 (a)단계의 제조한 발효 민들레 추출액 95 중량%와 대추 농축액 3 중량% 및 당귀 농축액 2 중량%를 혼합하는 단계를 포함할 수 있다.(b) mixing the 95% by weight of the fermented dandelion extract prepared in the step (a) with 3% by weight of the jujube concentrate and 2% by weight of the ginseng concentrate, based on the total weight of the mixed dandelion extract solution.
본 발명은 또한, 상기 방법으로 제조된 두뇌 쾌적 증진 효과를 지니는 민들레 혼합 추출액을 제공한다.
The present invention also provides a mixed extract of dandelion having a brain-comfort enhancing effect produced by the above-described method.
이하, 본 발명을 실시예에 의해 상세히 설명한다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예에 한정되는 것은 아니다.
Hereinafter, the present invention will be described in detail with reference to examples. However, the following examples are illustrative of the present invention, and the present invention is not limited to the following examples.
제조예Manufacturing example 1. 민들레 혼합 추출액 1. Dandelion mixed extract
(a) 청정지역인 강원도 양구에서 재배한 민들레의 줄기 및 뿌리 부위를 수확하여 즉시 세척 및 건조한 후 분말화하여 민들레 분말을 준비하였다.(a) The stem and root parts of the dandelion cultivated in a clean area, Gangwon-do, were harvested and immediately washed, dried and powdered to prepare dandelion powder.
(b) 상기 (a)단계의 준비한 민들레 분말 95 중량%와 프락토올리고당 분말 4.9 중량%를 혼합한 혼합물을 스팀살균기를 이용하여 110℃의 스팀으로 20분 동안 살균하고 40℃ 이하로 냉각한 후, 황국균(Aspergillus oryzae) 0.1 중량%를 혼합한 혼합물에 배양에 적합한 점도(혼합물 대비 10~20%)로 살균수를 첨가하였다. 상기 살균수를 첨가한 혼합물을 37℃ 및 상대습도 60% 이상에서 48~72시간 동안 배양하여 민들레 발효물을 제조하였다. 상기 제조한 민들레 발효물에 물을 10배(v/w) 첨가한 후 97℃에서 압력 1.0~2.0 kgf/cm2로 유지하면서 12시간 동안 추출한 후 여과(5 ㎛ 필터)하여 발효 민들레 추출액을 제조하였다.(b) A mixture of 95% by weight of the dandelion powder prepared in the step (a) and 4.9% by weight of fructooligosaccharide powder was sterilized with steam at 110 ° C for 20 minutes using a steam sterilizer, , Aspergillus oryzae ) in an amount of 0.1% by weight was added with sterilized water at a viscosity (10 to 20% based on the mixture) suitable for culturing. The mixture containing the sterilized water was cultured at 37 DEG C and a relative humidity of 60% or more for 48 to 72 hours to prepare a dandelion fermented product. The fermented dandelion extract was prepared by adding
(c) 상기 (b)단계의 제조한 발효 민들레 추출액 95 중량%와 대추 농축액 3 중량% 및 당귀 농축액 2 중량%를 90℃에서 30분 동안 교반하면서 혼합하여 민들레 혼합 추출액을 제조하였다.
(c) 95% by weight of the fermented dandelion extract prepared in the step (b), 3% by weight of the jujube concentrate and 2% by weight of the concentrate were mixed with stirring at 90 ° C for 30 minutes to prepare a mixed dandelion extract.
실시예Example 1. 민들레 혼합 추출액이 뇌파에 미치는 영향 분석 1. Effects of Dandelion Mixture Extract on EEG
민들레 혼합 추출액의 시음이 인간의 뇌 활동에 어떠한 영향을 주었는지를 알고자 뇌파를 측정하였다. 뇌파 측정은 최대한 잡음이 혼입되지 않은 온도 23℃, 습도 50%가 유지되는 32.4 m2 크기의 실험실에서 남, 녀 각각 10명 총 20명의 피험자를 대상으로 수행하였다. 뇌파측정을 위해 사용한 뇌파측정기는 QEEG-64FX 시스템(LXE3208, LAXTHA Inc. 한국)이었으며, 피험자의 뇌파신호 측정은 LAXTHA사의 데이터 수집 장비 및 분석 프로그램(Telescan)을 이용하였다. 피험자들에게 10~20 국제표준전극 부착법을 이용하여 좌측과 우측 전전두엽(Fp1, Fp2, Fpz, Af3, Af4, Afz), 좌측과 우측 전두엽(F3, F4, F7, F8, Fz, Fc1, Fc2, Fc5, Fc6), 좌측과 우측 측두엽(T3, T4, T7, T8, Cp5, Cp6), 좌측과 우측 두정엽(P3, P4, P7, P8, Cp1, Cp2, Cz, Pz), 좌측과 우측 후두엽(O1, O2, Oz) 부분에 부착하고 오른쪽과 왼쪽 귓불에도 각각 그라운드 및 레퍼런스 전극을 부착하였다(도 1 및 2). 피험자가 눈을 감은 상태에서 맹물 시음(무자극)과 민들레 혼합 추출액 시음(유자극)으로 하여 각각 45초씩 측정하였다. We measured the EEG by knowing the influence of the tasting of the dandelion mixed extract on human brain activity. EEG measurements were performed on a total of 20 subjects, 10 of each male and female, in a laboratory of 32.4 m 2 in which the noise was not mixed and the temperature was maintained at 23 ° C and 50% humidity. The brain waves were measured using the QEEG-64FX system (LXE3208, LAXTHA Inc. Korea). The EEG signals of the subjects were measured using LAXTHA's data collection equipment and analysis program (Telescan). The left and right prefrontal cords (Fp1, Fp2, Fpz, Af3, Af4, Afz), left and right frontal lobes (F3, F4, F7, F8, Fz, Fc1, Fc2, Left and right temporal lobes (P3, P4, P7, P8, Cp1, Cp2, Cz, Pz), left and right temporal lobes (T3, T4, T7, T8, Cp5, Cp6) O1, O2, and Oz), and ground and reference electrodes were attached to the right and left earlobes, respectively (FIGS. 1 and 2). Subjects were measured for 45 seconds with a blind tasting (no irritation) and a mixed extract of dandelion (unstimulated) with eyes closed.
민들레 혼합 추출액에 대한 뇌파측정을 통해 얻어진 데이터 처리는 피험자의 뇌파신호 중 대표적인 30초간의 뇌파신호만을 추출하여 뇌파일괄처리 프로그램(batch processing)으로 수행한 후, 통계분석 소프트웨어 프로그램인 SPSS(SPSS 23.0 version)를 이용하여 대응표본 T 검정을 수행하였다.The data processing obtained by EEG measurement on the mixed extract of dandelion extracts only the representative 30-second EEG signals among the EEG signals of the subject and performed by batch processing of brain waves. Then, statistical analysis software program SPSS (SPSS 23.0 version ) Was used to perform a corresponding sample T test.
민들레 혼합 추출액에 대한 데이터 분석을 위한 뇌파 지표의 종류는 표 1에, 그리고 각각의 뇌파 지표의 의미는 표 2에 나타내었다.
Table 1 shows the types of EEG indicators for analyzing data on the mixed dandelion extracts, and Table 2 shows the meanings of the EEG indices.
본 실시예에서 민들레 혼합 추출액에 대한 뇌파측정 결과, 25개의 뇌파분석 지표 중 RFA(Relative fast alpha power spectrum), ASEF(Spectral edge frequency 50% of alpha spectrum band) 지표에서만 통계학적인 유의성이 있는 것으로 나타났다(p<0.05). 나머지 23개의 파워스펙트럼은 차이가 발견되지 않았기 때문에 본 실시예에서는 기술하지 않았다.
In the present example, EEG data were statistically significant only in 25 EEG (Relative Fast Alpha Power Spectrum) and ASEF (Spectral edge frequency 50% of alpha spectrum band) p < 0.05). The remaining 23 power spectra were not described in this embodiment because no difference was found.
1. RFA(Relative fast alpha power spectrum) 지표1. Relative fast alpha power spectrum (RFA)
RFA 지표는 뇌파 스펙트럼에서 전체 주파수 영역의 절대파워에 대한 fast alpha 대역의 절대파워 비로서 fast alpha파 영역(11~13 Hz)으로 나누어 준 상대 파워 스펙트럼 값을 의미한다. 민들레 혼합 추출액 시음 시 뇌파분석 지표인 RFA 평균값이 통계적으로 유의미하게 증가하였다(p<0.05).The RFA indicator is the relative power spectrum value divided by the fast alpha wave range (11 ~ 13 Hz) as the absolute power ratio of the fast alpha band to the absolute power of the entire frequency domain in the EEG spectrum. The mean value of RFA, which is an indicator of EEG analysis, increased statistically when tasting mixed dandelion extract ( p <0.05).
2. ASEF(Spectral edge frequency 50% of alpha spectrum band) 지표2. ASEF (Spectral edge frequency 50% of alpha spectrum band)
ASEF 지표는 alpha파의 SEF50으로 쾌적성을 나타내는 뇌파지표로 alpha파의 뇌파 활성도를 확인할 수 있다고 알려져 있다. 민들레 혼합 추출액 시음 시 뇌파분석 지표인 ASEF 평균값이 통계적으로 유의미하게 증가하였다(p<0.05).The ASEF index is an alpha wave SEF50, which is known to be an EEG indicator indicating comfort. The mean value of ASEF, which is an indicator of EEG analysis, increased significantly during tasting of dandelion mixed extract ( p <0.05).
상기의 결과들을 토대로, 본 발명의 민들레 혼합 추출액의 섭취를 통해 뇌파의 변화를 유도하여 두뇌 쾌적 증진 효과를 나타낼 수 있음을 알 수 있었다.
Based on the above results, it was found that the intake of the mixed dandelion extract of the present invention induces a change in brain waves, thereby exhibiting a brain comfort enhancing effect.
Claims (7)
Dandelion powder, fructooligosaccharide powder and Aspergillus oryzae strain were mixed in a weight ratio of 94 to 96: 4 to 6: 0.08 to 0.12, water was added, and the mixture was stirred at 30 to 45 ° C for 48 to 72 hours 94 to 96% by weight of fermented dandelion extract, 2 to 4% by weight of jujube concentrate, and Angelica keiskei kotatsu (fermented soybean curd) were added to the fermented fermented product at a temperature of 95 to 100 DEG C for 5 to 20 times (v / (Relative fast alpha power spectrum) in the left prefrontal cortex, the right frontal cortex, the left temporal lobe, the right temporal lobe, the central occipital lobe, the right parietal lobe, the central parietal lobe, and the left parietal lobe And increasing the ASEF (spectral edge frequency 50% of the alpha spectrum band) in the middle prefrontal cortex.
A health functional food for enhancing brain comfort comprising the dandelion mixed extract composition according to claim 1.
The composition according to claim 4, further comprising at least one compound selected from the group consisting of vitamins, minerals, flavors, colorants, pectic acid and salts thereof, alginic acid and salts thereof, organic acids, protective colloid thickening agents, pH adjusting agents, stabilizers, preservatives, glycerin, And a carbonating agent used in a carbonated drink. ≪ RTI ID = 0.0 > 21. < / RTI >
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170108824A KR101847375B1 (en) | 2017-08-28 | 2017-08-28 | Dandelion mixed extract composition for improving brain comfort when tasting and uses thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020170108824A KR101847375B1 (en) | 2017-08-28 | 2017-08-28 | Dandelion mixed extract composition for improving brain comfort when tasting and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
KR101847375B1 true KR101847375B1 (en) | 2018-04-11 |
Family
ID=61976005
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020170108824A KR101847375B1 (en) | 2017-08-28 | 2017-08-28 | Dandelion mixed extract composition for improving brain comfort when tasting and uses thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101847375B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101997023B1 (en) * | 2018-11-30 | 2019-07-05 | 강원대학교산학협력단 | Hydrangea macrophylla extract mixed composition for relaxation and reducing concentration and uses thereof |
KR101997028B1 (en) * | 2018-11-30 | 2019-07-05 | 강원대학교산학협력단 | Mixed composition of lactic acid bacteria for enhancing awakening and uses thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101349592B1 (en) * | 2013-05-22 | 2014-02-13 | 김성문 | Fragrance chemicals on relaxation and comfortable states of brain function by decreasing beta wave at left prefrontal region and spectral edge frequency 50% value at right preforntal region |
-
2017
- 2017-08-28 KR KR1020170108824A patent/KR101847375B1/en active IP Right Grant
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101349592B1 (en) * | 2013-05-22 | 2014-02-13 | 김성문 | Fragrance chemicals on relaxation and comfortable states of brain function by decreasing beta wave at left prefrontal region and spectral edge frequency 50% value at right preforntal region |
Non-Patent Citations (1)
Title |
---|
윤미경 외 5명, ‘한방차가 시설이용 노인의 뇌기능지수에 미치는 효과’, 동서간호학연구지 제19권제2호, 128-137쪽, 2013년 11월. |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101997023B1 (en) * | 2018-11-30 | 2019-07-05 | 강원대학교산학협력단 | Hydrangea macrophylla extract mixed composition for relaxation and reducing concentration and uses thereof |
KR101997028B1 (en) * | 2018-11-30 | 2019-07-05 | 강원대학교산학협력단 | Mixed composition of lactic acid bacteria for enhancing awakening and uses thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102687888B (en) | Spina date seed beverage, and preparation method and application thereof | |
CN103637319A (en) | Pear soup beverage and preparation method for same | |
KR101817055B1 (en) | Food composition having anti-obesity, anti-cancer, anti-oxidative and immunity enhancing activities | |
KR101915031B1 (en) | Method for producing functional dutch coffee for relieving woman menopausal symptoms using Punica granatum fruit and Pueraria lobata root extracts | |
KR101847375B1 (en) | Dandelion mixed extract composition for improving brain comfort when tasting and uses thereof | |
KR100872552B1 (en) | Manufacturing method of soup using medical herbs and soup thereof | |
CN105249065B (en) | A kind of grape apple composite beverage for improving immunity | |
JP2017189160A (en) | Manufacturing method of akebia quinata extract and functional food using the extract | |
CN105249102A (en) | Health-care vinegar drink improving immunity | |
KR101997023B1 (en) | Hydrangea macrophylla extract mixed composition for relaxation and reducing concentration and uses thereof | |
KR101922466B1 (en) | Method for producing Hydrangea macrophylla tea having attention and concentration strengthening effect | |
KR20190057618A (en) | Ripe persimmon jelly comprising herbal ingredients and manufacturing method thereof | |
Ashok et al. | Nutraceutical values of minor fruits on immunity development to combat diseases | |
KR101541107B1 (en) | Oriental melon grain syrub manufacturing method and oriental melon grain syrub | |
KR102173430B1 (en) | Anti-inflammatory composition comprising complex fremented extract of Platycodon grandiflorum and herbal extract, and preparing method thereof | |
KR101980599B1 (en) | Mixed fermentation solution composition of Orostachys japonica and pine needle for enhancing attention and concentration and uses thereof | |
KR101855741B1 (en) | Mixed composition of β-carotene for relaxation and uses thereof | |
KR101203790B1 (en) | Method for manufacturing soybean paste including butterbur and soybean paste thereof | |
CN107095296B (en) | Method for making selenium-rich red date medlar ginger soup | |
KR100953958B1 (en) | Manufacturing method of knife-cut noodles | |
KR101877290B1 (en) | Aroma composition with grape flavor containing essential oil of Schisandra chinensis and Angelica gigas for enhancing concentration state and uses thereof | |
CN109287916A (en) | A kind of preparation method of Sessileflower Acanthopanax Bark extracting solution and its beverage | |
CN105168574A (en) | Healthcare maca oral solution and preparation method thereof | |
KR102520908B1 (en) | Preparation of aged solution of fruit of dioscorea opposita thumb, and aged solution of fruit of dioscorea opposita thumb prepared thereby | |
KR20190052958A (en) | Aronia fermentation solution composition for relaxation and uses thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |